Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

DTS, SRS Labs Unveil Expiration Of HSR Waiting Period On Proposed Acquisition

RELATED NEWS
Trade DTSI now with 
6/1/2012 9:12 AM ET

DTS Inc. (DTSI: Quote) and SRS Labs Inc. (SRSL: Quote) announced that the waiting period as per the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in relation with the prior announced definitive deal under which DTS would buy all outstanding shares of SRS Labs, has expired.

Accordingly, the condition to the completion of the merger related to the HSR Act has been satisfied. DTS and SRS Labs continue to anticipate that the transaction would close in the third quarter of 2012.

Click here to receive FREE breaking news email alerts for DTS INC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
First-time claims for U.S. unemployment benefits fell by more than expected in the week ended May 18th, according to a report released by the Labor Department on Thursday. The report showed that initial jobless claims fell to 340,000, a decrease of 23,000 from the previous week's revised figure of 363,000. After moving notably lower over the course of the previous session, stocks are likely to see further downside in early trading on Thursday. The major index futures are currently pointing to a sharply lower open for the markets, with the Dow futures down by 123 points. The U.K. economy avoided recession in the first quarter as initially estimated, but the detailed breakdown of gross domestic product highlighted major contribution coming only from built up stocks of companies. Gross domestic product grew 0.3 percent sequentially in the first quarter, offsetting the last quarter's 0.3 percent fall, second estimates from the Office for National Statistics showed.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.